3D PLANNING IN FRACTURE SURGERY
Across the globe, around 180 million bone fractures occur worldwide per year with 20 million that require surgical fixation. In orthopaedics, the practice of surgery has advanced, yet fracture planning via digital innovation has lagged other areas of clinical practice.
Recognising this gap, new platform technology has been created to leverage cutting-edge digital medicine, including virtual reality (VR), and artificial intelligence (AI) to recreate a patient’s fracture in a virtual 3D model.
OrthoVis’ target customers include individual orthopaedic surgeons, hospitals and trauma centres, academic institutions and medical device companies. The OrthoVis technology also has applications in other market segments including dental and maxillofacial surgery, spinal surgery, neurosurgery and veterinary surgery. Through the creation of the OrthoVis solution, surgeons can now meticulously plan and rehearse surgeries, addressing the critical needs.
contact: innovation@glasgow.ac.uk
THE TEAM
The OrthoVis team is a combination of clinical, technical, and commercial expertise, including an orthopaedic surgeon and experts from both the colleges of Science & Engineering and Medical, Veterinary & Life Sciences. The team has expertise in computational mathematics and machine learning, critical for product development. In addition, the team has both academic and business strategy contribution, which supports the breadth of requirements for commercialisation.
MEDTECH INNOVATION FUND SUPPORT
The MedTech Innovation Fund has provided support to OrthoVis to undertake comprehensive market evaluations, prioritising the US, Europe, and the UK as key markets. The funding also enhances customer discovery and stakeholder engagement, facilitating product demonstrations. OrthoVis are navigating the regulatory landscape, ensuring compliance and paving a clear, robust roadmap. These activities compliment other support from the University for an AI module, promising to bolster the platform’s functionality and generating valuable IP.
Next steps include further refining the intellectual property strategy and developing a minimum viable product (MVP) grounded in user feedback and building strategic partnerships crucial for market access.
FINAL OVERVIEW
OrthoVis have raised circa £350K to date and are on a path to redefine surgical planning, promising to enhance patient outcomes and streamline surgeon workflows. They are between Technology Readiness Level 2&3 and stand poised to transform fracture surgery and beyond.
More information: orthovis.co.uk